Expression of cathelicidin (CAMP) and TLRs (TLR5, 7, 8 and 9) was not significantly altered in COPD cores, while secretory leucocyte protease inhibitor (SLPI) expression was increased in mild COPD cores, as well as in moderate COPD cores as compared with controls. This evidence concerns the gene SLPI and chronic obstructive pulmonary disease.